Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues-Reference-Cited by-同舟云学术

Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues

Published:2008-07 Issue:2 Volume:102 Page:177-182
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Span Paul N.,Witjes Johannes A.,Grebenchtchikov Nicolai,Geurts-Moespot Anneke,Moonen Paula M.J.,Aalders Tilly W.,Vriesema Jessica L.J.,Kiemeney Lambertus A.L.M.,Schalken Jack A.,Sweep Fred C.G.J.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2008.07568.x/fullpdf

Reference34 articles.

1. Plasminogen activators, tissue degradation, and cancer;Danø;Adv Cancer Res,1985

2. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy;Schmitt;Thromb Haemost,1997

3. Urokinase plasminogen activator: a prognostic marker in multiple types of cancer;Duffy;J Surg Oncol,1999

4. 00 form of the human plasminogen activator, urokinase;Vassalli;J Cell Biol,1985

5. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells;Cubellis;J Biol Chem,1986

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrin and Fibrinolysis in Cancer;Seminars in Thrombosis and Hemostasis;2019-04-30

2. Relationship between the genetic expression of WTAP and bladder cancer and patient prognosis;Oncology Letters;2018-10-05

3. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications;Frontiers in Oncology;2018-02-12

4. Parameters of hemostatic potential in various stages of bladder cancer;Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology;2018

5. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival;Oncotarget;2017-02-24